A 35-year-old man with Guillain-Barre syndrome and ethylene diamine tetraacetic acid (EDTA)-dependent pseudothrombocytopenia associated with serologically-confirmed mumpsis presented. A polyneuropathy developed 18 days after the onset of mumps, that improved with plasmapheresis. A decreased platelet count was observed 25 days after the onset of mumps attributed to platelet agglutination in blood anticoagulated with EDTA,and the agglutination was prevented by other anticoagulants. Guillain-Barre syndromeassociated with mumpsis rare and EDTA-dependent pseudothrombocytopenia following mumpshas never been documented. This represents the first report of Guillain-Barre syndrome and EDTA-dependentpseudothrombocytopenia following mumps.Furthermore, our findings suggest activation of the humoral immune response as a potential pathogenesis. (Internal Medicine 35: 996-999, 1996) 
Introduction
Guillain-Barre syndromeassociated with mumps is very rare ( 1 ) . Only five cases have been reported (2) (3) (4) (5) (6) . Although the mechanism underlying this association is unclear, it has been suggested that immunologic mechanisms play a role in GuillainBarre syndrome (7) . Ethylene diamine tetraacetic acid (EDTA)-dependent pseudothrombocytopenia is the phenomenonof a spuriously low platelet count due to the presence of agglutinating antiplatelet antibodies that react with platelets in blood anticoagulated with EDTA (8) . In this report, we present a patient with Guillain-Barre syndrome, complicated by EDTA-dependent pseudothrombocytopenia, following mumps.
Case Report
A 35-year-old man was admitted to our department on April 15, 1994, because of abnormalities on liver function tests such as serum alanine aminotransferase (ALT) of 1 13 IU//. Two weeks before admission, he had developed bilateral painful parotid gland swelling and had experienced pain and swelling in his right testis. He had no history of mumps. His son had had mumps in March 1994 (Fig. 1 ). On admission, he was afebrile, and neither swelling of the parotid glands nor testes was detected. Neither lymphadenopathy nor hepatosplenomegaly was observed. Neurologic examination was negative. Laboratory findings are shown in Platelets (EDTA-anti-coagulated sample) weaknessof the respiratory muscles developed, the patient was intubated and received assisted ventilation. Plasmapheresis was started on the 6th hospital day, and he had four exchanges. By the 9th hospital day, an improvement in muscle strength was observed and he was extubated on the 14th hospital day. Repeat analysis of cerebrospinal fluid revealed 3 cells/jal, all lymphocytes, with an elevated protein content (6 1 mg/dl) on the 16th hospital day (Fig. 1) . By May, he had sustained a complete functional recovery. The clinical and laboratory features were thought to be consistent with established diagnostic criteria for
Guillain-Barre syndrome (9).
Twodays after plasmaphresis was finished, an electronic counting machine estimated the platelet count, anticoagulated with EDTA, at 4.3 x 104/jllL A peripheral-blood smear in blood anticoagulated with EDTAshowed platelet agglutination. Large platelet masses in EDTA-anticoagulated samples were not counted as platelets, resulting in spuriously low platelet counts.
When a blood sample was anticoagulated with heparin, which prevented in vitro clumping, the machine read 22.3 x 104/jnl. This condition was diagnosed as EDTA-dependent pseudothrombocytopenia.
At present, this pseudothrombocytopenia has been continued ( Fig. 1 ).
Discussion
Guillain-Barre syndrome is an acute polyneuropathy. Approximately two-thirds of the cases of Guillain-Barre syndrome follow an infection (7), usually viral in origin. However, GuillainBarre syndrome associated with mumpsis rare (1). Only five cases of Guillain-Barre syndrome cases (2-6, Table 2 ) and 12
cases ofpolyneuritis ( 10-1 6) associated with mumpshave been previously reported. Assessment of the clinical features of Guillain-Barre syndrome following mumps revealed that all cases involved men, four of whomhad suffered preceding mumpsorchitis.
A polyneuropathy usually develops 3 to 18 days following mumpsand a facial palsy is observed in 50%of patients (Table   2 ). These findings indicate that Guillain-Barre syndrome following mumpsessentially does not differ from that following other infections. The complications of mumpsinclude Guillain-B arre syndrome, acute disseminated encephalomyelitis , thrombocytopenic purpura, and arthritis, which have been postulated to be mediated by humoral immuneresponses or cell-mediated immunologic phenomena ( 1 7-1 9) . In addition, Guillain-Barre syndromeis a knowncomplication of vaccination for mumps (20) .
Plasmapheresis has recently been reported to be effective in a number of clinical trials (21, 22) , and sera from patients with
Guillain-Barre syndrome following Campylobacter jejuni infections have contained IgM and IgG antibodies against GM1 ganglioside during the acute phase of the illness (23) (24) (25) . These results suggest that humoral immuneresponses contribute to the pathogenesis of Guillain-Barre syndrome.
EDTA-dependentpseudothrombocytopenia is an in vitro laboratory artifact associated with the use of EDTAanticoagulant in blood collection tubes. It results in the in vitro clumping of platelets and consequent erroneous underestimation of platelet counts by electronic counters. Theunderlying mechanismof EDTA-dependent pseudothrombocytopenia has been studied by several investigators. IgG antibodies that react with platelets Functional grade (FG) defined using the following scale: 0 = healthy; 1 = minor signs or symptoms; 2 = able to walk 5 meters without assistance; 3 = able to walk 5 meters with assistance; 4 = bed-or chair-bound; 5 = requires assisted ventilation (22) .
are found most frequently in EDTA-dependent pseudothrombocytopenia; however, combinations of IgG and IgA, IgM alone, and cold reactive IgA also have been described (8, (26) (27) (28) (29) (30) . It has been shown that the antigenic determinant of the EDTA-dependent antibodies may be the GP Ilb/IIIa complex (29) . EDTA-dependent pseudothrombocyotpenia is most frequently observed in patients with prolonged severe illnesses (8, 3 1) , and is frequently associated with autoimmune, neoplastic, or liver diseases (8) . There has been no report ofGuillain-Barre syndrome associated with EDTA-dependentpseudothrombocytopenia. Furthermore, despite several reports of EDTAdependent pseudothrombocytopenia associated with a viral infection, e.g., CMV,rubella, and viral hepatitis A (32-34), there has been no report of that associated with mumps. In summary, this represents the first case report of GuillainBarre syndrome and EDTA-dependentpseudothrombocytopenia following mumps. On the basis of our findings, we suggest that both Guillain-B arre syndrome and EDTA-dependent pseudothrombocytopenia may be caused by the humoral immuneresponse. Although the cases have been too few to permit determination of the pathogenic mechanisms involving these complications and mumps, mumps seemsto trigger the humoral immuneresponse.
